Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

In this episode of Speaking of Urology®, former Major League Baseball (MLB) player, Dave Winfield, shares lessons he’s learned throughout his professional baseball career and his work in philanthropy. Winfield delivered a keynote presentation at this year’s LUGPA Annual Meeting titled, “Leadership Lessons Learned from Baseball, Business and Philanthropy.”

In this episode of Speaking of Urology®, Juan J. Andino, MD, MBA, speaks with Robert E. Brannigan, MD on the recent amendment to the American Urological Association (AUA) guideline on male infertility. This discussion originally took place during a live X (formerly Twitter) Spaces event held by Urology Times®.

In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen. Winter is a urologist and sexual medicine expert in Los Angeles, California.

In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy for urology and recap the American Urological Association’s (AUA) recent Annual Urology Advocacy Summit, which took place from February 26-28 in Washington DC.

In this interview, Adam B. Murphy, MD, MBA, MSCI, discusses the need to increase diversity in clinical trials, specifically focusing on studies in prostate cancer.

In this episode of Speaking of Urology®, David M. Albala, MD, and Sanoj Punnen, MD, discuss precision medicine and the use of biomarker tests in prostate cancer screening and detection. Albala is the chief of urology at Crouse Hospital in Syracuse, New York, and Punnen is an associate professor of urologic oncology and an associate professor and vice chair of research at the Desai Sethi Urology Institute at the University of Miami in Florida.

This discussion originally took place during a live X (formerly Twitter) Spaces event held by Urology Times. In this exclusive interview, Albala and Punnen discussed the significance of advances such as liquid biopsies in prostate cancer, reviewed the current liquid biopsy tests available, and shared their own clinical experiences with the tests in their practice. They also highlighted data on the ExoDx prostate test from studies of clinical utility and validation studies.1,2,3

Albala and Punnen ended their discussion by highlighting current ed

In this interview, Janelle Bunce, PA-C highlights the role that advanced practice providers (APPs) can play in filling the gaps created by the growing workforce shortages in urology. Bunce is a physician assistant at Advanced Urology Institute in Naples, Florida.

In this episode, David M. Schuster, MD, FACR, highlights the recent FDA approval of flotufolastat F 18 (POSLUMA), a PSMA-PET imaging agent in prostate cancer. Schuster is a professor of radiology and imaging sciences and the director of the division of nuclear medicine and molecular imaging at Emory University School of Medicine in Atlanta, Georgia.

In this episode, Ashish M. Kamat, MD, MBBS, highlights the state of bladder cancer care in honor of Bladder Cancer Awareness Month this May.